Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
1,065 total articles
Uber is generating real free cash flow and earnings while trading at a single-digit-ish P/E for a tech-enabled platform. That disconnect creates a tradeable mid-term opportunity into Q4 results: buy a measured position on weakness, protect with a clear stop, and target a re-rating if margins or guidance stabilize.
Texas Instruments is breaking out of a multi-year range after Q4 2025 strength and bullish 2026 guidance. With Data Center end-market growth, steady Industrial demand, a sizeable dividend, and a disciplined capital return program, TXN looks positioned for a multi-month gain. The trade below balances momentum and valuation risk with a clear stop and…
Baidu sits at the intersection of steady ad cash flow, fast-growing AI/cloud revenue and a plausible corporate-finance pivot toward dividends or buybacks. At a $54.3B market cap and a PE near 49, the stock is priced for continued growth but also offers an asymmetric setup if management signals a shareholder-return program. This trade idea targets a…
Charter (CHTR) trades around 6x reported earnings with roughly $4.4B in annual free cash flow and an enterprise value of ~$122B. Leverage is high, but the business generates consistent broadband cash flow, trades well below historical multiples, and has clear catalysts (broadband market tailwinds, potential legal clarity, and cost discipline). We u…
Oracle announced a $45-50 billion funding plan to bulk up Oracle Cloud Infrastructure. That plan flips a typical cloud-growth story into an execution-and-financing event. Given high leverage, negative free cash flow, and a stretched valuation, this is a pragmatic mid-term short (45 trading days) to capture further normalization as investors digest …
B2Gold's Goose Mine has moved from commissioning to commercial production and is slated to contribute roughly 300,000 ounces per year from 2026-2031. That ramp creates a clear path to a step-change in free cash flow relative to the company's current market capitalization. This trade idea outlines a long-biased position to capture the re-rating as o…
ASML's monopoly on EUV lithography is powering another leg of compounding: record Q4 orders (€13.2bn), 2026 guidance raised to €34-39bn and a €12bn buyback underpin growth and capital returns. Technicals show bullish momentum, but a steep valuation (PE ~51, PB ~24.7) and China exposure create near-term jolt risk. Trade plan: go long at $1426.74, ta…
Booking Holdings (BKNG) has drifted off recent highs and is trading below several moving averages with an RSI under 40. Fundamentals remain solid: high free cash flow, profitable operations and a market cap near $162B. For traders, a disciplined entry near $5,000 with a $4,850 stop and a $5,600 target offers asymmetric risk-reward over the next 45 …
Sandisk surged after a blowout Q2 2026, driven by AI datacenter demand, strong gross margins and aggressive guidance. Valuation looks rich on multiples but justified by revenue acceleration and free cash flow. This trade idea lays out an entry at $590.00, stop at $540.00 and a target of $760.00 for a mid-term swing trade (45 trading days), with cle…
Allegro MicroSystems has shown accelerating revenue in industrial and automotive segments, producing strong free cash flow while market multiples remain rich but justifiable if growth persists. We outline a swing trade that leans on industrial demand and technical momentum with a clear entry, stop and target.
Parex Resources (PARXF) has threaded a series of higher moving averages, a bullish MACD and a rising RSI while short interest remains extremely high. This trade idea targets a momentum-driven rally into the mid-$17s with a defined stop under the 50-day moving average. High short interest means volatility can work for or against you - position sizin…
Insmed shares have been knocked around by negative headlines on the development side, but the company already has a commercially approved DPP1 inhibitor, BRINSUPRI, with consensus peak sales potential near $5 billion. With a market cap of roughly $33.5 billion and supportive technicals, this trade idea buys the pullback into what we view as an othe…
ServiceNow's Now Platform is increasingly central to enterprise automation and AI-driven workflows. Q4 results show $3.57B revenue and 21% YoY growth, while balance sheet strength and $4.58B free cash flow give the company runway to integrate recent AI-focused acquisitions. The stock is materially oversold (RSI ~25) and trading near its 52-week low…
Great Lakes Dredge & Dock (GLDD) trades at a reasonable multiple against a $1B+ backlog, improving margins and favorable industry tailwinds. We upgrade to a buy with a mid-term target of $18.00 and a protective stop at $13.50.
Archer (ACHR) is advancing toward first commercial eVTOL operations with clear near-term catalysts (UAE approval, LA28 preparations, defense work) but still operates with negative earnings and material cash burn. This trade captures asymmetric upside into 2026 catalysts while limiting downside through a defined stop.
Intel's heavy hardware bet - high-NA EUV, 14A/18A node roadmaps and a potential Apple foundry relationship - creates a measurable trade setup. The company is priced for turnaround but not for a successful execution of its foundry and data center AI growth. This trade idea buys the gap between current skepticism and a plausible operational pickup ov…
Moog (MOG.A) has run to a new 52-week high on renewed investor interest in aerospace and space systems. The company pairs double-digit ROE, healthy free cash flow and modest leverage with exposure to fast-growing space sensors and aircraft components markets. This trade calls for a long position at $305.00 with a $360.00 target and a $285.00 stop, …
AMD looks positioned to widen its lead over Intel in 2026 as hyperscalers diversify AI infrastructure away from a single-vendor GPU market. The balance sheet is healthy, cash generation is solid, and technicals show constructive momentum. This trade idea lays out an entry at $237.00, a stop at $200.00 and a primary target of $375.00 over a 180 trad…
Abercrombie & Fitch (ANF) just pulled back into its 10-day simple moving average after a strong 2025 earnings cadence. The company still generates healthy free cash flow ($384.5M) and trades at an attractive P/E (~8.6) versus its growth and cash profile. This trade idea lays out a mid-term (45 trading days) swing to $120 with a tight stop to limit …
Millicom has finished the heavy lifting: consolidation in Colombia, targeted M&A in Ecuador, and infrastructure monetizations have materially improved cash flow visibility. At a market cap near $10.2B, a sub-4x run-rate EV/EBITDA implied valuation, a 4.9% yield and single-digit P/E, TIGO looks positioned for a cash-flow rerating. This trade idea la…
Nuvation Bio (NUVB) has traded off sharply since its 52-week high, but supportive rollout commentary on Ibtrozi, a solid cash position and a beaten-down technical set create an asymmetric risk/reward for a measured long. This trade idea lays out entry, stop and target with horizon and risk framing.
AMD has moved from niche contender to essential infrastructure partner for hyperscalers that are building out AI datacenters. With a $385B market cap, improving data center traction, positive technical momentum, and attractive free cash flow generation, AMD is a high-conviction swing trade ahead of the quarter-end print. Entry, stop, and target are…
Ciena is benefiting from a second wave of AI infrastructure spending as hyperscalers and cloud providers expand high-capacity optical links inside and between data centers. Strong orders and a growing backlog have driven an outsized stock move, but valuation is rich. This trade idea favors a disciplined long with entry at $252.00, a $320.00 target …
Zoom (ZM) is trading at a reasonable multiple for a profitable SaaS franchise with improving technicals and solid free cash flow. For investors who want asymmetric upside into the next wave of generative AI, pairing a long Zoom position with selective pre-IPO Anthropic exposure (via secondaries or funds where available) creates a balanced risk-rewa…
Protalix (PLX) is a small-cap biotech with a near-term March decision risk/reward. The company trades at roughly $187M market cap, has no debt, and carries enough cash to fund operations near-term. If the March regulatory outcome is positive, shares can re-test prior highs quickly; if negative, downside is clear. This trade idea lays out an entry a…
